Understanding the latest FDA guidance on investigational new drugs for cell and gene therapy

On the 28th January 2020 we saw the FDA update its guidance for industry regarding chemistry, manufacturing, and control (CMC) on the application of (INDs) for cell and gene therapy, including assurance of clonality and stable cell line development. Innovation driving gene therapy Within this document the FDA provides guidance to the industry and to …

Read more Understanding the latest FDA guidance on investigational new drugs for cell and gene therapy

Duncan Borthwick joins Solentim as Global Marketing Manager

Solentim, the leader in cell line biopharmaceutical instruments, is pleased to announce that Dr Duncan Borthwick will join the Company as the new Global Marketing Manager. Duncan has a strong commercial background in bringing new technologies to international markets. With a PhD from Edinburgh University, his previous work experience includes life science distribution companies Cambridge …

Read more Duncan Borthwick joins Solentim as Global Marketing Manager

The Challenges & Demands when Establishing a New Cell Line Development Lab

Ian Taylor will share his expertise on purchasing the right platform solution at SLAS 2020 Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be presenting and exhibiting at SLAS 2020, taking place 25-29 January, San Diego. The event showcases the latest cutting-edge developments in laboratory automation and screening, …

Read more The Challenges & Demands when Establishing a New Cell Line Development Lab